My Quote Request
6505-00-072-9346
20 Products
SORBITRATE TABLETS
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
SORBITRATE TABLETS
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
ASTRAZENECA LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00143-1767-01
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
NDC00143-1767-01
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00310-0760-10
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
NDC00310-0760-10
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
ASTRAZENECA LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-0368-01
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
NDC00364-0368-01
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
SCHEIN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00555-0173-02
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
NDC00555-0173-02
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00603-4123-21
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
NDC00603-4123-21
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00904-2343-60
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
NDC00904-2343-60
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SORBITRATE
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
SORBITRATE
ISOSORBIDE DINITRATE SUBLINGUAL TABLETS,USP
NSN, MFG P/N
6505000729346
NSN
6505-00-072-9346
MFG
ASTRAZENECA LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE TABLETS USP 5 MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
AG0RAL
PHENOLPHTHALEIN AND MINERAL OIL EMULSION
NSN, MFG P/N
6505000730542
NSN
6505-00-073-0542
AG0RAL
PHENOLPHTHALEIN AND MINERAL OIL EMULSION
NSN, MFG P/N
6505000730542
NSN
6505-00-073-0542
MFG
WARNER-CHILCOTT LABORATORIES DIV OF WARNER-LAMBERT PHARMACEUTICAL CO CUSTOMER SERVICE DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 31.000 PERCENTAGE, W/V MINERAL OIL ACTIVE INGREDIENT AND 12.000 MILLIGRAMS PHENOLPHTHALEIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
1700
QUININE SULFATE TABLETS,USP
NSN, MFG P/N
6505000730543
NSN
6505-00-073-0543
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS QUININE SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00002-0336-02
QUININE SULFATE TABLETS,USP
NSN, MFG P/N
6505000730543
NSN
6505-00-073-0543
NDC00002-0336-02
QUININE SULFATE TABLETS,USP
NSN, MFG P/N
6505000730543
NSN
6505-00-073-0543
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS QUININE SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00019-0926-15
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505000742976
NSN
6505-00-074-2976
NDC00019-0926-15
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505000742976
NSN
6505-00-074-2976
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: INTRA-ARTERIAL OR INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
FERRO-SEQUELS
FERROUS FUMARATE AND DOCUSATE SODIUM EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505000742981
NSN
6505-00-074-2981
FERRO-SEQUELS
FERROUS FUMARATE AND DOCUSATE SODIUM EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505000742981
NSN
6505-00-074-2981
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.56 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 36.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.071 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.63 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FERROUS FUMARATE 150.000 MG (EQUIVALENT TO 50.000 MG OF ELEMENTAL IRON);RELEASES IRON OVER A 4 TO 6 HOUR PERIOD;LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
NDC00005-4612-34
FERROUS FUMARATE AND DOCUSATE SODIUM EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505000742981
NSN
6505-00-074-2981
NDC00005-4612-34
FERROUS FUMARATE AND DOCUSATE SODIUM EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505000742981
NSN
6505-00-074-2981
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.56 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 36.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.071 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.63 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FERROUS FUMARATE 150.000 MG (EQUIVALENT TO 50.000 MG OF ELEMENTAL IRON);RELEASES IRON OVER A 4 TO 6 HOUR PERIOD;LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
00039-0004-10
DANTHRON AND DOCUSATE CALCIUM CAPSULES
NSN, MFG P/N
6505000743169
NSN
6505-00-074-3169
00039-0004-10
DANTHRON AND DOCUSATE CALCIUM CAPSULES
NSN, MFG P/N
6505000743169
NSN
6505-00-074-3169
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.70 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 180
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 63.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.009 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.36 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS DANTHRON ACTIVE INGREDIENT AND 60.000 MILLIGRAMS DOCUSATE CALCIUM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: LIQUID
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DOXIDAN
DANTHRON AND DOCUSATE CALCIUM CAPSULES
NSN, MFG P/N
6505000743169
NSN
6505-00-074-3169
DOXIDAN
DANTHRON AND DOCUSATE CALCIUM CAPSULES
NSN, MFG P/N
6505000743169
NSN
6505-00-074-3169
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.70 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 180
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 63.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.009 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.36 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS DANTHRON ACTIVE INGREDIENT AND 60.000 MILLIGRAMS DOCUSATE CALCIUM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: LIQUID
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MYCIFRADIN
NEOMYCIN SULFATE ORAL SOLUTION,USP
NSN, MFG P/N
6505000743958
NSN
6505-00-074-3958
MYCIFRADIN
NEOMYCIN SULFATE ORAL SOLUTION,USP
NSN, MFG P/N
6505000743958
NSN
6505-00-074-3958
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 17.500 MILLIGRAMS NEOMYCIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00002-1452-01
VINBLASTINE SULFATE,USP
NSN, MFG P/N
6505000744101
NSN
6505-00-074-4101
NDC00002-1452-01
VINBLASTINE SULFATE,USP
NSN, MFG P/N
6505000744101
NSN
6505-00-074-4101
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINBLASTINE SULFATE STERILE USP 10 MG BOTTLE
PHYSICAL FORM: FREEZE-DRIED CRYSTAL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
VELBAN
VINBLASTINE SULFATE,USP
NSN, MFG P/N
6505000744101
NSN
6505-00-074-4101
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINBLASTINE SULFATE STERILE USP 10 MG BOTTLE
PHYSICAL FORM: FREEZE-DRIED CRYSTAL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
HYDR0PRES
HYDROCHLOROTHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505000744104
NSN
6505-00-074-4104
HYDR0PRES
HYDROCHLOROTHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505000744104
NSN
6505-00-074-4104
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 0.125 MILLIGRAMS RESERPINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE